Project Grant HT94252410679
Award Date
9/30/24
Completion Date
9/29/26
Dollars Obligated
$384K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Cleveland, OH 44195, USA
Similar Awards
The U.S. Department of Defense's Defense Health Agency (DHA) awarded a $2,602,024 Project Grant to The Cleveland Clinic Foundation under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on September 30, 2024, will fund research on the "Role of Stress in the Degradation of Intestinal IgA and Intestinal Health" over a 4-year period ending on September 29, 2028. As a prominent academic medical center, The Cleveland Clinic Foundation...
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $650,138 Project Grant to The Cleveland Clinic Foundation on September 1, 2024. The grant will fund a 2-year study focused on developing biomarkers to assess patient response to neurorestorative therapies for cervical spinal cord injuries. The Cleveland Clinic Foundation, a non-profit academic medical center, will leverage its expertise in neuroscience research to advance this...
The Defense Health Agency awarded a $799,998 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Cleveland Clinic Foundation in Cleveland, Ohio. The grant, with a performance period from September 2025 to September 2028, supports research aimed at developing strategies to enhance spinal plasticity and promote recovery from spinal cord injury. As a renowned nonprofit academic medical center, The Cleveland Clinic Foundation will leverage its expertise...
The Defense Health Agency awarded The Cleveland Clinic Foundation, a non-profit academic medical center, a $893,768 Project Grant under the Military Medical Research and Development (CFDA 12.420) program. The two-year grant, effective from September 1, 2023 to August 31, 2025, supports the development of multimodal AI-based solutions to enhance renal cancer patient care. As a leader in medical research, education, and healthcare delivery, The Cleveland Clinic Foundation will leverage its...
The U.S. Defense Health Agency awarded a $559,992 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Cleveland Clinic Foundation. The grant supports the "Bench-to-Bedside Development of Superior CAR T-Cell Therapy for Leukemia" research project, which aims to transform healthcare for military service members, veterans, and the public through innovative biomedical research. The project will run from September 30, 2025 to September 29, 2028,...
The Department of Defense's Defense Health Agency has awarded a $1,917,278 Project Grant to The Cleveland Clinic Foundation under the Military Medical Research and Development (CFDA 12.420) program. The purpose of this 3-year grant, effective July 1, 2025, is to support research on developing a novel treatment called Neupron for acute spinal cord injury. The grant aims to identify surrogate biomarkers that can be used to evaluate the treatment's efficacy. As a renowned nonprofit academic medical...
The Cleveland Clinic Foundation will receive $400,000 from the Defense Health Agency under a two-year Project Grant award through the Military Medical Research and Development program (CFDA 12.420). The grant will support research from July 1, 2023 to June 30, 2025 to investigate the role of microglia and the NLRP3 inflammasome in contributing to non-motor deficits associated with Parkinson's disease. The Military Medical Research and Development program aims to transform military and public...
The Department of Defense's Defense Health Agency awarded a $1,280,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Cleveland Clinic Foundation. The grant, awarded on September 1, 2025, supports research investigating the biological mechanisms and therapeutic relevance of the SLC1A1 amino acid transporter in kidney cancer. The Cleveland Clinic Foundation, a renowned nonprofit academic medical center, will conduct this advanced biomedical research...
The Cleveland Clinic Foundation was awarded a $712,508 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period of September 1, 2022 through August 31, 2025. The grant aims to assess the role of glycated apolipoprotein A1 (apoA1) in relation to cognitive complications of diabetes and preclinical Alzheimer's disease. As the primary awardee, Cleveland Clinic will analyze glycated apoA1 levels in plasma samples from...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $999,999 Project Grant to The Cleveland Clinic Foundation to conduct research on "Inhibiting Demyelination Rescues Synapse Loss in Multiple Sclerosis." The grant period runs from June 1, 2024 to May 31, 2027. The Cleveland Clinic Foundation, a non-profit academic medical center, will use the funding to carry out innovative biomedical research aimed at developing new treatments...